Multiple myeloma: increasing evidence for a multistep transformation process.
Hallek
M
M
Medizinische Klinik, Klinikum Innenstadt, and Genzentrum, Universität M-unchen, M-unchen, Germany.
Bergsagel
P L
PL
Anderson
K C
KC
D000954:Antigens, Surface / Q000502:physiology; D017209:Apoptosis / Q000235:genetics; D001853:Bone Marrow / Q000473:pathology; D015815:Cell Adhesion Molecules / Q000502:physiology; D002453:Cell Cycle; D002471:Cell Transformation, Neoplastic; D004273:DNA, Neoplasm / Q000235:genetics; D018432:Drug Resistance, Multiple / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D016161:Genes, Retinoblastoma; D005812:Genes, Switch; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D015850:Interleukin-6 / Q000502:physiology; D008198:Lymph Nodes / Q000473:pathology; D009101:Multiple Myeloma / Q000209:etiology* / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009857:Oncogenes; D010950:Plasma Cells / Q000473:pathology*; D015398:Signal Transduction; D014178:Translocation, Genetic; D000093242:Interleukin-6 Inhibitors
D000954:Antigens, Surface; D015815:Cell Adhesion Molecules; D004273:DNA, Neoplasm; D006133:Growth Substances; D007143:Immunoglobulin Heavy Chains; D015850:Interleukin-6; D000093242:Interleukin-6 Inhibitors